🚨Don't miss the 4th #LIVERAIM webinar!
Early detection of Chronic Liver Disease in primay care: real-world perspectives
🗓️Tomorrow, 16:15-17:CET
register here: tinyurl.com/72wsnejv
@ihieurope.bsky.social @easlnews.bsky.social
🚨 Don't miss the third webinar of the #LIVERAIM series!
📹 youtube.com/watch?v=qdM_...
#SLDthinktank
@jvlazarus.bsky.social @ihieurope.bsky.social @easlnews.bsky.social @majathiele.bsky.social @salvatore-piano.bsky.social @aleksanderkrag.bsky.social
😶Liver disease is often suffered in silence.
Stigma and shame block care.
💡It’s a chronic illness, not consequence of bad choices.
🩺Everyone deserves support.
At #LIVERAIM, we’re breaking the silence.
#EndTheStigma #LiverHealthMatters #HealthEquity
@ihieurope.bsky.social @easlnews.bsky.social
🧠 Insightful discussions at the #LIVERAIM session at #ILC2025!
🎯We explored how #biomarkers + #AI can boost early detection of #liverfibrosis and improve care for #chronicliverdiseases.
👉See you at the EASL Studio!
#EASLCongress
@ihieurope.bsky.social @easlnews.bsky.social
#LIVERAIM networking session has started at track hub8!
Join us and learn how #biomarkers of #liverfibrosis can reshape the future of Hepatology
#livertwitter #EASLCongress @aleksanderkrag.bsky.social @ihieurope.bsky.social @salvatore-piano.bsky.social @easlnews.bsky.social @IHI
🚨Join #LIVERAIM at the #ILC2025 Track Hub!
🗓️7 May 13:30 CEST
🎯 Biomarkers in #LIVERAIM project
With Dr. Elisa Pose, Dr. Jorn Scahhtenberg and and reps from industry partners
📌Track Hub 8 – see you there!
@ihieurope.bsky.social @easlnews.bsky.social @europeliver.bsky.social
This #WorldLiverDay, we stand strong with patients across Europe!
With @liveraim.bsky.social, we’re pioneering early detection & personalized care for liver disease.
Innovation. Hope. Action.
#LiverHealth #PatientPower @ihieurope.bsky.social #HorizonEurope #LIVERAIM @jvlazarus.bsky.social
❓Did you miss the second #LIVERAIM webinar?
Check out our Youtube channel and discover what an #earlydiagnosis of #chronicliverdisease truly means for patients!
🎥 www.youtube.com/watch?v=jmw5...
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
📌Tomorrow is the day: don't miss the 2nd #LIVERAIM webinar!
✒️Register now! tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social @mkdmilan.bsky.social @majathiele.bsky.social @worldhepalliance.bsky.social
⌛️4 day left!
Join 2nd #LIVERAIM webinar and learn what patients really think about #earlydiagnosis: the hopes, the fears, and the reality!
🗓️3 March 17:30-18:10 CET
👉Register now tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social
📣 The second #LIVERAIM webinar is on the way!
Early diagnosis of chronic liver disease - What does it mean for patients?
🗓️ 3 March 17:30-18:10 CET
🔗 Register now! tinyurl.com/4j97xhp9
#earlydiagnosis #changingtheparadigm
@easlnews.bsky.social @aleksanderkrag.bsky.social @jvlazarus.bsky.social
🆕Investigadores del #CLÍNIC-#IDIBAPS y del CIBEREHD han liderado un estudio europeo para evaluar la eficacia de una combinación de tractamientos en pacientes con #cirrosis descompensada
@hospitalclinic.bsky.social
👉https://s.mtrbio.com/aqhxbnmzwx
#LiverScreen #LiverAim #liverdisease
🆕Investigadors del #CLÍNIC-#IDIBAPS i del CIBEREHD han liderat un estudi europeu per avaluar l'eficàcia d'una combinació de tractaments en pacients amb #cirrosi descompensada
@hospitalclinic.bsky.social
👉https://s.mtrbio.com/tiemjehsam
#LiverScreen #LiverAim #liverdisease
🆕Researchers from #CLÍNIC-#IDIBAPS and the CIBEREHD have led a European study to evaluate the efficacy of a combination of treatments for patients with decompensated #cirrhosis
@hospitalclinic.bsky.social
👉https://s.mtrbio.com/wwzeyoyqpg
#LiverScreen #LiverAim #liverdisease
